Recursion Pharmaceuticals Inc. stock reached a 52-week low, closing at $2.98. The biotechnology company, with a market capitalization of $1.58 billion, now trades 58% below its 52-week high of $7.18.

NEW YORK and SALT LAKE CITY, March 31, 2026 (GLOBE NEWSWIRE) — Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with Recursion ...

Warning: this article contains spoilers for Dune: Part 2! Check out our spoiler-free review of Dune: Part 2. There was a guy sitting two rows behind me at my screening of Dune: Part 2 who, as the ...

Warning: This article contains full spoilers for Dune: Part 2. Science-fiction nerds and IMAX enthusiasts rejoice, because Denis Villeneuve’s Dune: Part 2 (review) has already made big waves on its ...

Madonna is returning to the discothèque. Two decades after the release of her beloved album Confessions on a Dance Floor, the Queen of Pop has been hard at work on a sequel. “I’m putting my heart and ...

S11 - E17 Reunion Part 2 The "Southern Charm" reunion continues as Venita emotionally confronts Salley about feeling betrayed. Charley shares an exciting update about her dating status, but a shocking ...